In This Issue: Chile’s National Congress is considering legislation that would require women seeking abortions to be offered the opportunity to hear their unborn child’s heartbeat before an abortion. The measure would strengthen informed consent and give mothers an opportunity to connect with their baby.
In This Issue: Ireland recorded 10,600 abortions in 2025, a 59.02% increase from 6,666 in 2019, the first-year abortion on demand became legal. The latest figures bring the total number of abortions since legalization to nearly 60,000.
In This Issue: Planned Parenthood, the nation’s largest abortion provider, has resumed billing Medicaid for non-abortion services after nearly a year without federal reimbursements. The organization has claimed that the funding cut contributed to the closure of nearly 30 of its roughly 600 clinics, along with a 25% decline in birth control distribution and a 20% drop in breast cancer screenings.
In This Issue: France has introduced additional paid parental leave in an effort to address its worsening birth rate. Under the new policy, mothers and fathers can share up to two extra months of leave, receiving 70% of their net salary during the first month and 60% during the second month.
In This Issue: Four years after the Dobbs decision, abortion pills obtained through telehealth continue reshaping the abortion landscape. By December 2025, 29% of U.S. abortions were due to telehealth, with abortion providers increasingly relying on mail-order distribution to reach women in states with pro-life protections.
In This Issue: A new peer-reviewed study from the Charlotte Lozier Institute found significant gaps in informed consent for women undergoing chemical abortions. Researchers analyzed 179 narratives from online media and surveyed 362 women who had taken abortion drugs within the past five years. 30% of women reported experiencing more pain and bleeding than expected, while many sought information online about abortion side effects and emotional distress.
In This Issue: Two new studies have linked smartphones to plunging birthrates. In the U.S., the iPhone rollout in 2007 coincided with falling fertility rates, and counties with early AT&T coverage saw the sharpest declines. The most pronounced effects were among those ages 15 to 24, accounting for as much as half of the 2007–2011 drop.
In This Issue: After years of relentless decline, South Korea’s fertility rate showed an unexpected increase, rising from a record-low 0.72 children per woman in 2023 to 0.75 in 2024 and 0.80 in 2025. March births surged 19.4% year-over-year to 25,200, the highest March total since 2019.
In This Issue: A new report found abortion drugs are now widely available online in all 50 states, often in violation of federal and state laws. The study identified eight online-only organizations shipping abortion pills into pro-life states, while only 19% of online abortion providers complied with the FDA’s 70-day safety limit.
In This Issue: After temporarily preserving abortion pill access last week, the U.S. Supreme Court has now formally blocked a lower court ruling that would have restored in-person restrictions on mifepristone, keeping nationwide telehealth and mail-order distribution in place while the case proceeds.
In This Issue: Chile’s National Congress is considering legislation that would require women seeking abortions to be offered the opportunity to hear their unborn child’s heartbeat before an abortion. The measure would strengthen informed consent and give mothers an opportunity to connect with their baby.
In This Issue: Ireland recorded 10,600 abortions in 2025, a 59.02% increase from 6,666 in 2019, the first-year abortion on demand became legal. The latest figures bring the total number of abortions since legalization to nearly 60,000.
In This Issue: Planned Parenthood, the nation’s largest abortion provider, has resumed billing Medicaid for non-abortion services after nearly a year without federal reimbursements. The organization has claimed that the funding cut contributed to the closure of nearly 30 of its roughly 600 clinics, along with a 25% decline in birth control distribution and a 20% drop in breast cancer screenings.
In This Issue: France has introduced additional paid parental leave in an effort to address its worsening birth rate. Under the new policy, mothers and fathers can share up to two extra months of leave, receiving 70% of their net salary during the first month and 60% during the second month.
In This Issue: Four years after the Dobbs decision, abortion pills obtained through telehealth continue reshaping the abortion landscape. By December 2025, 29% of U.S. abortions were due to telehealth, with abortion providers increasingly relying on mail-order distribution to reach women in states with pro-life protections.
In This Issue: A new peer-reviewed study from the Charlotte Lozier Institute found significant gaps in informed consent for women undergoing chemical abortions. Researchers analyzed 179 narratives from online media and surveyed 362 women who had taken abortion drugs within the past five years. 30% of women reported experiencing more pain and bleeding than expected, while many sought information online about abortion side effects and emotional distress.
In This Issue: Two new studies have linked smartphones to plunging birthrates. In the U.S., the iPhone rollout in 2007 coincided with falling fertility rates, and counties with early AT&T coverage saw the sharpest declines. The most pronounced effects were among those ages 15 to 24, accounting for as much as half of the 2007–2011 drop.
In This Issue: After years of relentless decline, South Korea’s fertility rate showed an unexpected increase, rising from a record-low 0.72 children per woman in 2023 to 0.75 in 2024 and 0.80 in 2025. March births surged 19.4% year-over-year to 25,200, the highest March total since 2019.
In This Issue: A new report found abortion drugs are now widely available online in all 50 states, often in violation of federal and state laws. The study identified eight online-only organizations shipping abortion pills into pro-life states, while only 19% of online abortion providers complied with the FDA’s 70-day safety limit.
In This Issue: After temporarily preserving abortion pill access last week, the U.S. Supreme Court has now formally blocked a lower court ruling that would have restored in-person restrictions on mifepristone, keeping nationwide telehealth and mail-order distribution in place while the case proceeds.